Benchmark secures licensing deal for state-of-the-art Canine Atopic Dermatitis vaccine
Benchmark has secured an exclusive worldwide license from Saiba Animal Health GmbH, to develop and commercialise a recombinant vaccine for Canine Atopic Dermatitis (CAD) using Virus Like-Particle (VLP) technology.
